Item 1. | Security and Issuer |
This Schedule 13D relates to common stock, par value $0.01 per share (the “Shares), of Iridex Corporation (“IRIX” or the “Company”) with its principal executive offices located at 1212 Terra Bella Avenue, Mountain View, CA, 94043. This statement is filed jointly pursuant to Commission Rule 13d-1(k)(1).
Item 2. | Identity and Background |
This statement is filed on behalf of the following reporting persons (collectively, the “Reporting Persons”):
| (a) | Brent Alexander Roland, a permanent resident of the United States and citizen of Canada (“B. Roland”). |
| (b) | Leigh Ann Roland, a permanent resident of the United States and citizen of Canada (“L. Roland”). |
| (c) | Roland Family Support Trust, a trust established under the laws of the State of Arizona (the “Trust”). |
| (d) | Glenn Cuthbert Roland, a citizen of the United States (“G. Roland”). |
B. Roland is the contact point for this filing. Set forth on Schedule A to this statement, and incorporated herein by reference, is the (a) name, (b) residence or business address, and (c) present principal occupation or employment and the name, principal business and address of any corporation or other organization in which such employment is conducted, of each Reporting Person.
During the last five years, none of the Reporting Persons has been (a) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (b) party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
Item 3. | Source and Amount of Funds or Other Considerations |
All of the funds used in making the purchase of the Shares described in Item 5 of this Schedule 13D came from the personal funds of the individual Reporting Persons and the funds of the Trust.
Item 4. | Purpose of Transaction |
The Reporting Persons have purchased the Shares for investment purposes.
The Reporting Persons leave open the possibility of communicating with management of the Company to discuss future strategy.
Item 5. | Interest in Securities of the Issuer |
As of the date of this Schedule 13D, each of the Reporting Persons may be deemed to own 881,998 Shares. Such Shares represent 5.52% of Shares outstanding based on 15,985,622 Shares outstanding as of August 11, 2022 as reported in the Company’s 10-Q filed with the Securitas and Exchange Commission for the Company’s Fiscal quarter ended June 30, 2022.